| Bruce Linder, MD | |
|
5495 Burr Oak Rd, Apt 505, Lisle, IL 60532-2158 | |
| (952) 595-1100 | |
| (612) 294-4903 |
| Full Name | Bruce Linder |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 42 Years |
| Location | 5495 Burr Oak Rd, Lisle, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023189214 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 036067266 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Macneal Hospital | Berwyn, IL | Hospital |
| Methodist Medical Center Of Illinois | Peoria, IL | Hospital |
| Proctor Hospital | Peoria, IL | Hospital |
| Pekin Memorial Hospital | Pekin, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Specialists In Medical Imaging Sc | 2163733544 | 201 |
| Smi Imaging Llc | 3476696220 | 239 |
| Loyola University Medical Center | 3779488903 | 863 |
| Simonmed Imaging Florida Llc | 6608036108 | 152 |
News Archive
FibroGen, Inc. (FibroGen), today announced that data from a China-based Phase 2 study of roxadustat (FG-4592), a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD), were presented in an oral session at the 2013 American Society of Nephrology (ASN) Kidney Week in Atlanta, Georgia.
The aging of the population, shifting diagnostic criteria, and new health care policy initiatives are some of the factors driving changes in mental health treatment for older Americans, according to the September special issue of the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer.
Health officials in Indonesia have confirmed the first human death from bird flu in Bali in a village in the north-west district of Jembrana, an area where poultry is known to be affected.
In a medical breakthrough two blind men have regained partial sight for the first time in more than 20 years after receiving a "bionic eye". Scientists said the first clinical trials of the microchip eye implant, which measures just 3mm across and is fitted behind the eyeball, have proved successful and "exceeded expectations".
Archimedes Pharma Ltd., a leading international specialty pharma company, today announced the decision by the Scottish Medicines Consortium to accept PecFent for use within NHS Scotland. PecFent is indicated for the treatment of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.
› Verified 1 days ago
| Entity Name | Loyola University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336159961 PECOS PAC ID: 3779488903 Enrollment ID: O20031202000027 |
News Archive
FibroGen, Inc. (FibroGen), today announced that data from a China-based Phase 2 study of roxadustat (FG-4592), a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD), were presented in an oral session at the 2013 American Society of Nephrology (ASN) Kidney Week in Atlanta, Georgia.
The aging of the population, shifting diagnostic criteria, and new health care policy initiatives are some of the factors driving changes in mental health treatment for older Americans, according to the September special issue of the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer.
Health officials in Indonesia have confirmed the first human death from bird flu in Bali in a village in the north-west district of Jembrana, an area where poultry is known to be affected.
In a medical breakthrough two blind men have regained partial sight for the first time in more than 20 years after receiving a "bionic eye". Scientists said the first clinical trials of the microchip eye implant, which measures just 3mm across and is fitted behind the eyeball, have proved successful and "exceeded expectations".
Archimedes Pharma Ltd., a leading international specialty pharma company, today announced the decision by the Scottish Medicines Consortium to accept PecFent for use within NHS Scotland. PecFent is indicated for the treatment of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.
› Verified 1 days ago
| Entity Name | Metropolitan Advanced Radiological Services Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689613804 PECOS PAC ID: 7315849817 Enrollment ID: O20040124000072 |
News Archive
FibroGen, Inc. (FibroGen), today announced that data from a China-based Phase 2 study of roxadustat (FG-4592), a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD), were presented in an oral session at the 2013 American Society of Nephrology (ASN) Kidney Week in Atlanta, Georgia.
The aging of the population, shifting diagnostic criteria, and new health care policy initiatives are some of the factors driving changes in mental health treatment for older Americans, according to the September special issue of the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer.
Health officials in Indonesia have confirmed the first human death from bird flu in Bali in a village in the north-west district of Jembrana, an area where poultry is known to be affected.
In a medical breakthrough two blind men have regained partial sight for the first time in more than 20 years after receiving a "bionic eye". Scientists said the first clinical trials of the microchip eye implant, which measures just 3mm across and is fitted behind the eyeball, have proved successful and "exceeded expectations".
Archimedes Pharma Ltd., a leading international specialty pharma company, today announced the decision by the Scottish Medicines Consortium to accept PecFent for use within NHS Scotland. PecFent is indicated for the treatment of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.
› Verified 1 days ago
| Entity Name | Medical Diagnostic Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992962682 PECOS PAC ID: 5890893275 Enrollment ID: O20071108000682 |
News Archive
FibroGen, Inc. (FibroGen), today announced that data from a China-based Phase 2 study of roxadustat (FG-4592), a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD), were presented in an oral session at the 2013 American Society of Nephrology (ASN) Kidney Week in Atlanta, Georgia.
The aging of the population, shifting diagnostic criteria, and new health care policy initiatives are some of the factors driving changes in mental health treatment for older Americans, according to the September special issue of the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer.
Health officials in Indonesia have confirmed the first human death from bird flu in Bali in a village in the north-west district of Jembrana, an area where poultry is known to be affected.
In a medical breakthrough two blind men have regained partial sight for the first time in more than 20 years after receiving a "bionic eye". Scientists said the first clinical trials of the microchip eye implant, which measures just 3mm across and is fitted behind the eyeball, have proved successful and "exceeded expectations".
Archimedes Pharma Ltd., a leading international specialty pharma company, today announced the decision by the Scottish Medicines Consortium to accept PecFent for use within NHS Scotland. PecFent is indicated for the treatment of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.
› Verified 1 days ago
| Entity Name | Specialists In Medical Imaging Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841687951 PECOS PAC ID: 2163733544 Enrollment ID: O20150626000251 |
News Archive
FibroGen, Inc. (FibroGen), today announced that data from a China-based Phase 2 study of roxadustat (FG-4592), a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD), were presented in an oral session at the 2013 American Society of Nephrology (ASN) Kidney Week in Atlanta, Georgia.
The aging of the population, shifting diagnostic criteria, and new health care policy initiatives are some of the factors driving changes in mental health treatment for older Americans, according to the September special issue of the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer.
Health officials in Indonesia have confirmed the first human death from bird flu in Bali in a village in the north-west district of Jembrana, an area where poultry is known to be affected.
In a medical breakthrough two blind men have regained partial sight for the first time in more than 20 years after receiving a "bionic eye". Scientists said the first clinical trials of the microchip eye implant, which measures just 3mm across and is fitted behind the eyeball, have proved successful and "exceeded expectations".
Archimedes Pharma Ltd., a leading international specialty pharma company, today announced the decision by the Scottish Medicines Consortium to accept PecFent for use within NHS Scotland. PecFent is indicated for the treatment of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.
› Verified 1 days ago
| Entity Name | Smi Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972004489 PECOS PAC ID: 3476696220 Enrollment ID: O20181212002794 |
News Archive
FibroGen, Inc. (FibroGen), today announced that data from a China-based Phase 2 study of roxadustat (FG-4592), a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD), were presented in an oral session at the 2013 American Society of Nephrology (ASN) Kidney Week in Atlanta, Georgia.
The aging of the population, shifting diagnostic criteria, and new health care policy initiatives are some of the factors driving changes in mental health treatment for older Americans, according to the September special issue of the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer.
Health officials in Indonesia have confirmed the first human death from bird flu in Bali in a village in the north-west district of Jembrana, an area where poultry is known to be affected.
In a medical breakthrough two blind men have regained partial sight for the first time in more than 20 years after receiving a "bionic eye". Scientists said the first clinical trials of the microchip eye implant, which measures just 3mm across and is fitted behind the eyeball, have proved successful and "exceeded expectations".
Archimedes Pharma Ltd., a leading international specialty pharma company, today announced the decision by the Scottish Medicines Consortium to accept PecFent for use within NHS Scotland. PecFent is indicated for the treatment of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.
› Verified 1 days ago
| Entity Name | Zwanger & Pesiri Radiology Group Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477523413 PECOS PAC ID: 5092700799 Enrollment ID: O20190708000007 |
News Archive
FibroGen, Inc. (FibroGen), today announced that data from a China-based Phase 2 study of roxadustat (FG-4592), a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD), were presented in an oral session at the 2013 American Society of Nephrology (ASN) Kidney Week in Atlanta, Georgia.
The aging of the population, shifting diagnostic criteria, and new health care policy initiatives are some of the factors driving changes in mental health treatment for older Americans, according to the September special issue of the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer.
Health officials in Indonesia have confirmed the first human death from bird flu in Bali in a village in the north-west district of Jembrana, an area where poultry is known to be affected.
In a medical breakthrough two blind men have regained partial sight for the first time in more than 20 years after receiving a "bionic eye". Scientists said the first clinical trials of the microchip eye implant, which measures just 3mm across and is fitted behind the eyeball, have proved successful and "exceeded expectations".
Archimedes Pharma Ltd., a leading international specialty pharma company, today announced the decision by the Scottish Medicines Consortium to accept PecFent for use within NHS Scotland. PecFent is indicated for the treatment of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.
› Verified 1 days ago
| Entity Name | Howard John Simon Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932768934 PECOS PAC ID: 1658602263 Enrollment ID: O20191107000153 |
News Archive
FibroGen, Inc. (FibroGen), today announced that data from a China-based Phase 2 study of roxadustat (FG-4592), a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD), were presented in an oral session at the 2013 American Society of Nephrology (ASN) Kidney Week in Atlanta, Georgia.
The aging of the population, shifting diagnostic criteria, and new health care policy initiatives are some of the factors driving changes in mental health treatment for older Americans, according to the September special issue of the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer.
Health officials in Indonesia have confirmed the first human death from bird flu in Bali in a village in the north-west district of Jembrana, an area where poultry is known to be affected.
In a medical breakthrough two blind men have regained partial sight for the first time in more than 20 years after receiving a "bionic eye". Scientists said the first clinical trials of the microchip eye implant, which measures just 3mm across and is fitted behind the eyeball, have proved successful and "exceeded expectations".
Archimedes Pharma Ltd., a leading international specialty pharma company, today announced the decision by the Scottish Medicines Consortium to accept PecFent for use within NHS Scotland. PecFent is indicated for the treatment of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.
› Verified 1 days ago
| Entity Name | Simonmed Imaging Florida Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477830818 PECOS PAC ID: 6608036108 Enrollment ID: O20191113002596 |
News Archive
FibroGen, Inc. (FibroGen), today announced that data from a China-based Phase 2 study of roxadustat (FG-4592), a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD), were presented in an oral session at the 2013 American Society of Nephrology (ASN) Kidney Week in Atlanta, Georgia.
The aging of the population, shifting diagnostic criteria, and new health care policy initiatives are some of the factors driving changes in mental health treatment for older Americans, according to the September special issue of the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer.
Health officials in Indonesia have confirmed the first human death from bird flu in Bali in a village in the north-west district of Jembrana, an area where poultry is known to be affected.
In a medical breakthrough two blind men have regained partial sight for the first time in more than 20 years after receiving a "bionic eye". Scientists said the first clinical trials of the microchip eye implant, which measures just 3mm across and is fitted behind the eyeball, have proved successful and "exceeded expectations".
Archimedes Pharma Ltd., a leading international specialty pharma company, today announced the decision by the Scottish Medicines Consortium to accept PecFent for use within NHS Scotland. PecFent is indicated for the treatment of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.
› Verified 1 days ago
| Entity Name | Howard Simon Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659930998 PECOS PAC ID: 7214369966 Enrollment ID: O20191118002405 |
News Archive
FibroGen, Inc. (FibroGen), today announced that data from a China-based Phase 2 study of roxadustat (FG-4592), a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD), were presented in an oral session at the 2013 American Society of Nephrology (ASN) Kidney Week in Atlanta, Georgia.
The aging of the population, shifting diagnostic criteria, and new health care policy initiatives are some of the factors driving changes in mental health treatment for older Americans, according to the September special issue of the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer.
Health officials in Indonesia have confirmed the first human death from bird flu in Bali in a village in the north-west district of Jembrana, an area where poultry is known to be affected.
In a medical breakthrough two blind men have regained partial sight for the first time in more than 20 years after receiving a "bionic eye". Scientists said the first clinical trials of the microchip eye implant, which measures just 3mm across and is fitted behind the eyeball, have proved successful and "exceeded expectations".
Archimedes Pharma Ltd., a leading international specialty pharma company, today announced the decision by the Scottish Medicines Consortium to accept PecFent for use within NHS Scotland. PecFent is indicated for the treatment of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.
› Verified 1 days ago
| Entity Name | Health Diagnostics Of California A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104321959 PECOS PAC ID: 4284621525 Enrollment ID: O20191205001928 |
News Archive
FibroGen, Inc. (FibroGen), today announced that data from a China-based Phase 2 study of roxadustat (FG-4592), a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD), were presented in an oral session at the 2013 American Society of Nephrology (ASN) Kidney Week in Atlanta, Georgia.
The aging of the population, shifting diagnostic criteria, and new health care policy initiatives are some of the factors driving changes in mental health treatment for older Americans, according to the September special issue of the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer.
Health officials in Indonesia have confirmed the first human death from bird flu in Bali in a village in the north-west district of Jembrana, an area where poultry is known to be affected.
In a medical breakthrough two blind men have regained partial sight for the first time in more than 20 years after receiving a "bionic eye". Scientists said the first clinical trials of the microchip eye implant, which measures just 3mm across and is fitted behind the eyeball, have proved successful and "exceeded expectations".
Archimedes Pharma Ltd., a leading international specialty pharma company, today announced the decision by the Scottish Medicines Consortium to accept PecFent for use within NHS Scotland. PecFent is indicated for the treatment of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.
› Verified 1 days ago
| Entity Name | Steward Radiology Physicians Of Arizona Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063052793 PECOS PAC ID: 9335563600 Enrollment ID: O20200804001699 |
News Archive
FibroGen, Inc. (FibroGen), today announced that data from a China-based Phase 2 study of roxadustat (FG-4592), a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD), were presented in an oral session at the 2013 American Society of Nephrology (ASN) Kidney Week in Atlanta, Georgia.
The aging of the population, shifting diagnostic criteria, and new health care policy initiatives are some of the factors driving changes in mental health treatment for older Americans, according to the September special issue of the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer.
Health officials in Indonesia have confirmed the first human death from bird flu in Bali in a village in the north-west district of Jembrana, an area where poultry is known to be affected.
In a medical breakthrough two blind men have regained partial sight for the first time in more than 20 years after receiving a "bionic eye". Scientists said the first clinical trials of the microchip eye implant, which measures just 3mm across and is fitted behind the eyeball, have proved successful and "exceeded expectations".
Archimedes Pharma Ltd., a leading international specialty pharma company, today announced the decision by the Scottish Medicines Consortium to accept PecFent for use within NHS Scotland. PecFent is indicated for the treatment of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.
› Verified 1 days ago
| Entity Name | Steward Radiology Physicians Of Pennsylvania Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255971974 PECOS PAC ID: 9234557125 Enrollment ID: O20210311000139 |
News Archive
FibroGen, Inc. (FibroGen), today announced that data from a China-based Phase 2 study of roxadustat (FG-4592), a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD), were presented in an oral session at the 2013 American Society of Nephrology (ASN) Kidney Week in Atlanta, Georgia.
The aging of the population, shifting diagnostic criteria, and new health care policy initiatives are some of the factors driving changes in mental health treatment for older Americans, according to the September special issue of the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer.
Health officials in Indonesia have confirmed the first human death from bird flu in Bali in a village in the north-west district of Jembrana, an area where poultry is known to be affected.
In a medical breakthrough two blind men have regained partial sight for the first time in more than 20 years after receiving a "bionic eye". Scientists said the first clinical trials of the microchip eye implant, which measures just 3mm across and is fitted behind the eyeball, have proved successful and "exceeded expectations".
Archimedes Pharma Ltd., a leading international specialty pharma company, today announced the decision by the Scottish Medicines Consortium to accept PecFent for use within NHS Scotland. PecFent is indicated for the treatment of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.
› Verified 1 days ago
| Entity Name | Golden State Imaging Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144872052 PECOS PAC ID: 1254761315 Enrollment ID: O20220422002003 |
News Archive
FibroGen, Inc. (FibroGen), today announced that data from a China-based Phase 2 study of roxadustat (FG-4592), a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD), were presented in an oral session at the 2013 American Society of Nephrology (ASN) Kidney Week in Atlanta, Georgia.
The aging of the population, shifting diagnostic criteria, and new health care policy initiatives are some of the factors driving changes in mental health treatment for older Americans, according to the September special issue of the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer.
Health officials in Indonesia have confirmed the first human death from bird flu in Bali in a village in the north-west district of Jembrana, an area where poultry is known to be affected.
In a medical breakthrough two blind men have regained partial sight for the first time in more than 20 years after receiving a "bionic eye". Scientists said the first clinical trials of the microchip eye implant, which measures just 3mm across and is fitted behind the eyeball, have proved successful and "exceeded expectations".
Archimedes Pharma Ltd., a leading international specialty pharma company, today announced the decision by the Scottish Medicines Consortium to accept PecFent for use within NHS Scotland. PecFent is indicated for the treatment of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bruce Linder, MD 11995 Singletree Ln, Ste 500, Eden Prairie, MN 55344-5347 Ph: (952) 595-1301 | Bruce Linder, MD 5495 Burr Oak Rd, Apt 505, Lisle, IL 60532-2158 Ph: (952) 595-1100 |
News Archive
FibroGen, Inc. (FibroGen), today announced that data from a China-based Phase 2 study of roxadustat (FG-4592), a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD), were presented in an oral session at the 2013 American Society of Nephrology (ASN) Kidney Week in Atlanta, Georgia.
The aging of the population, shifting diagnostic criteria, and new health care policy initiatives are some of the factors driving changes in mental health treatment for older Americans, according to the September special issue of the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer.
Health officials in Indonesia have confirmed the first human death from bird flu in Bali in a village in the north-west district of Jembrana, an area where poultry is known to be affected.
In a medical breakthrough two blind men have regained partial sight for the first time in more than 20 years after receiving a "bionic eye". Scientists said the first clinical trials of the microchip eye implant, which measures just 3mm across and is fitted behind the eyeball, have proved successful and "exceeded expectations".
Archimedes Pharma Ltd., a leading international specialty pharma company, today announced the decision by the Scottish Medicines Consortium to accept PecFent for use within NHS Scotland. PecFent is indicated for the treatment of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.
› Verified 1 days ago
Dr. Anand P Shah, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 430 Warrenville Rd, Lisle, IL 60532 Phone: 630-432-6745 | |
Dr. Jennifer Victoria Yilk, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 430 Warrenville Rd, Lisle, IL 60532 Phone: 630-946-2060 | |
Thomas A Shin, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 430 Warrenville Rd, Lisle, IL 60532 Phone: 630-432-6745 Fax: 630-432-6608 | |
Amar S Mehta, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 430 Warrenville Rd Ste 110, Lisle, IL 60532 Phone: 630-946-2020 | |
Dr. Katherine F Baker, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 430 Warrenville Rd, Lisle, IL 60532 Phone: 630-432-6745 | |
Ravi Ramakrishna, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 430 Warrenville Rd Ste 110, Lisle, IL 60532 Phone: 630-946-2020 Fax: 630-432-6754 |